- Home
- ACHV vs KGEI Comparison
ACHV vs KGEI Comparison
Compare ACHV & KGEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- KGEI
- Stock Information
- Founded
- ACHV N/A
- KGEI 2008
- Country
- ACHV Canada
- KGEI United States
- Employees
- ACHV N/A
- KGEI N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- KGEI
- Sector
- ACHV Health Care
- KGEI
- Exchange
- ACHV Nasdaq
- KGEI Nasdaq
- Market Cap
- ACHV 149.6M
- KGEI 131.8M
- IPO Year
- ACHV N/A
- KGEI N/A
- Fundamental
- Price
- ACHV $4.33
- KGEI $3.98
- Analyst Decision
- ACHV Strong Buy
- KGEI
- Analyst Count
- ACHV 5
- KGEI 0
- Target Price
- ACHV $14.80
- KGEI N/A
- AVG Volume (30 Days)
- ACHV 116.0K
- KGEI 15.0K
- Earning Date
- ACHV 11-07-2024
- KGEI 11-12-2024
- Dividend Yield
- ACHV N/A
- KGEI N/A
- EPS Growth
- ACHV N/A
- KGEI 4.29
- EPS
- ACHV N/A
- KGEI 0.48
- Revenue
- ACHV N/A
- KGEI $54,654,000.00
- Revenue This Year
- ACHV N/A
- KGEI $15.80
- Revenue Next Year
- ACHV N/A
- KGEI $12.21
- P/E Ratio
- ACHV N/A
- KGEI $8.25
- Revenue Growth
- ACHV N/A
- KGEI 16.56
- 52 Week Low
- ACHV $3.03
- KGEI $2.84
- 52 Week High
- ACHV $5.98
- KGEI $4.60
- Technical
- Relative Strength Index (RSI)
- ACHV 40.62
- KGEI 74.16
- Support Level
- ACHV $4.12
- KGEI $3.34
- Resistance Level
- ACHV $4.46
- KGEI $4.00
- Average True Range (ATR)
- ACHV 0.24
- KGEI 0.22
- MACD
- ACHV -0.05
- KGEI 0.06
- Stochastic Oscillator
- ACHV 17.65
- KGEI 98.17
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About KGEI Kolibri Global Energy Inc. Common stock
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. Its segments include the United States, Canada and Others. The company derives a majority of its revenue from the United States.